156 related articles for article (PubMed ID: 38173050)
1. Poly(lactic-co-glycolic) Acid (PLGA) Nanoparticles and Transdermal Drug Delivery: An Overview.
Kumar L; Kukreti G; Rana R; Chaurasia H; Sharma A; Sharma N; Komal
Curr Pharm Des; 2023; 29(37):2940-2953. PubMed ID: 38173050
[TBL] [Abstract][Full Text] [Related]
2. Micelle-templated, poly(lactic-
Nabar GM; Mahajan KD; Calhoun MA; Duong AD; Souva MS; Xu J; Czeisler C; Puduvalli VK; Otero JJ; Wyslouzil BE; Winter JO
Int J Nanomedicine; 2018; 13():351-366. PubMed ID: 29391794
[TBL] [Abstract][Full Text] [Related]
3. Biomedical applications of PLGA nanoparticles in nanomedicine: advances in drug delivery systems and cancer therapy.
Narmani A; Jahedi R; Bakhshian-Dehkordi E; Ganji S; Nemati M; Ghahramani-Asl R; Moloudi K; Hosseini SM; Bagheri H; Kesharwani P; Khani A; Farhood B; Sahebkar A
Expert Opin Drug Deliv; 2023; 20(7):937-954. PubMed ID: 37294853
[TBL] [Abstract][Full Text] [Related]
4. Dual tumor-targeted poly(lactic-
Chen J; Wu Q; Luo L; Wang Y; Zhong Y; Dai HB; Sun D; Luo ML; Wu W; Wang GX
Int J Nanomedicine; 2017; 12():5745-5760. PubMed ID: 28848351
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
[TBL] [Abstract][Full Text] [Related]
6. Cyrene™ as an Alternative Sustainable Solvent for the Preparation of Poly(lactic-co-glycolic acid) Nanoparticles.
Grune C; Thamm J; Werz O; Fischer D
J Pharm Sci; 2021 Feb; 110(2):959-964. PubMed ID: 33275992
[TBL] [Abstract][Full Text] [Related]
7. PLGA's Plight and the Role of Stealth Surface Modification Strategies in Its Use for Intravenous Particulate Drug Delivery.
Sheffey VV; Siew EB; Tanner EEL; Eniola-Adefeso O
Adv Healthc Mater; 2022 Apr; 11(8):e2101536. PubMed ID: 35032406
[TBL] [Abstract][Full Text] [Related]
8. Transdermal iontophoresis of flufenamic acid loaded PLGA nanoparticles.
Malinovskaja-Gomez K; Labouta HI; Schneider M; Hirvonen J; Laaksonen T
Eur J Pharm Sci; 2016 Jun; 89():154-62. PubMed ID: 27131608
[TBL] [Abstract][Full Text] [Related]
9. A Review on Designing Poly (Lactic-co-glycolic Acid) Nanoparticles as Drug Delivery Systems.
Naskar S; Das SK; Sharma S; Kuotsu K
Pharm Nanotechnol; 2021; 9(1):36-50. PubMed ID: 33319695
[TBL] [Abstract][Full Text] [Related]
10. PLGA-based nanoparticles as cancer drug delivery systems.
Sadat Tabatabaei Mirakabad F; Nejati-Koshki K; Akbarzadeh A; Yamchi MR; Milani M; Zarghami N; Zeighamian V; Rahimzadeh A; Alimohammadi S; Hanifehpour Y; Joo SW
Asian Pac J Cancer Prev; 2014; 15(2):517-35. PubMed ID: 24568455
[TBL] [Abstract][Full Text] [Related]
11. Engineered PLGA nanoparticles: an emerging delivery tool in cancer therapeutics.
Jain AK; Das M; Swarnakar NK; Jain S
Crit Rev Ther Drug Carrier Syst; 2011; 28(1):1-45. PubMed ID: 21395514
[TBL] [Abstract][Full Text] [Related]
12. Iontophoretic transdermal delivery using chitosan-coated PLGA nanoparticles for positively charged drugs.
Takeuchi I; Takeshita T; Suzuki T; Makino K
Colloids Surf B Biointerfaces; 2017 Dec; 160():520-526. PubMed ID: 29017147
[TBL] [Abstract][Full Text] [Related]
13. Development of transdermal vitamin D3 (VD3) delivery system using combinations of PLGA nanoparticles and microneedles.
Kim HG; Gater DL; Kim YC
Drug Deliv Transl Res; 2018 Feb; 8(1):281-290. PubMed ID: 29247316
[TBL] [Abstract][Full Text] [Related]
14. Poly-(lactic-
Orekhova A; Palocci C; Chronopoulou L; De Angelis G; Badiali C; Petruccelli V; D'Angeli S; Pasqua G; Simonetti G
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080191
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of mannosylated-PLGA nanoparticles of antiretroviral drug to brain.
Patel BK; Parikh RH; Patel N
Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):97-100. PubMed ID: 29593405
[TBL] [Abstract][Full Text] [Related]
16. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery.
Avgoustakis K
Curr Drug Deliv; 2004 Oct; 1(4):321-33. PubMed ID: 16305394
[TBL] [Abstract][Full Text] [Related]
17. Spermidine-mediated poly(lactic-
Tang J; Li J; Li G; Zhang H; Wang L; Li D; Ding J
Int J Nanomedicine; 2017; 12():6687-6704. PubMed ID: 28932114
[TBL] [Abstract][Full Text] [Related]
18. Improving cellular uptake and cytotoxicity of chitosan-coated poly(lactic-
Van Hees S; Elbrink K; De Schryver M; Delputte PL; Kiekens F
Nanomedicine (Lond); 2020 Nov; 15(27):2671-2688. PubMed ID: 33112210
[No Abstract] [Full Text] [Related]
19. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances of Multifunctional PLGA Nanocarriers in the Management of Triple-Negative Breast Cancer.
Dinakar YH; Rajana N; Kumari NU; Jain V; Mehra NK
AAPS PharmSciTech; 2023 Dec; 24(8):258. PubMed ID: 38097825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
